Market Cap 1.77B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 2,541,100
Avg Vol 7,828,502
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 22%
Beta 1.14
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tradersunion353
tradersunion353 Jul. 22 at 11:20 PM
$ABCL 2 dollars by end of the month bad phase 2 data confirmed as looking at the stock dropping every single day
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 8:49 PM
$ABCL comfirmed i guess phase 2 is bad look at the stock crashing
0 · Reply
Niconicai
Niconicai Jul. 22 at 8:34 PM
$RXRX $ABCL $ABSI $SDGR $XBI After President Trump said on The Axios Show that AI drug discovery could bring “medical cures 25 years early,” the White House today unveiled the $5B+ Genesis Mission, with one of its flagship initiatives focused on accelerating drug discovery and clinical translation using AI, combining molecular, genomic, phenotypic, clinical, and real-world data. AI drug discovery is clearly becoming a national priority.
2 · Reply
MrHurts
MrHurts Jul. 22 at 8:25 PM
$ABCL C'mon 😤😠
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 22 at 8:24 PM
$ABCL $ABCL dont be fooled, 2.5 million shares traded in a day is WAAAAY under volume.
0 · Reply
Rastafari
Rastafari Jul. 22 at 8:21 PM
$ABCL not the outcome I expected today, but stay calm. Our day is coming.
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 7:39 PM
$ABCL disgusting company
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 22 at 6:42 PM
$ABCL Share Price: $5.84 Contract Selected: Jan 15, 2027 $5 Calls Buy Zone: $1.53 – $1.89 Target Zone: $2.82 – $3.45 Potential Upside: 74% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 6:16 PM
$ABCL great this continues to drop as if there is no tomrrow . however management has zero accountability for share holders except paper tradees with adding and loafing repeated comments this POS stock has nothing
0 · Reply
8008track
8008track Jul. 22 at 5:55 PM
$ABCL for the record book - good or bad. I bought more today at $5.88. Not sure what the price action will be for the next couple of weeks but I’m happy to pick up additional shares and be invested. All that matters is abcl635 read out. 71 days remaining in q3.
1 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 15 days ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 16 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 16 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 6 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


tradersunion353
tradersunion353 Jul. 22 at 11:20 PM
$ABCL 2 dollars by end of the month bad phase 2 data confirmed as looking at the stock dropping every single day
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 8:49 PM
$ABCL comfirmed i guess phase 2 is bad look at the stock crashing
0 · Reply
Niconicai
Niconicai Jul. 22 at 8:34 PM
$RXRX $ABCL $ABSI $SDGR $XBI After President Trump said on The Axios Show that AI drug discovery could bring “medical cures 25 years early,” the White House today unveiled the $5B+ Genesis Mission, with one of its flagship initiatives focused on accelerating drug discovery and clinical translation using AI, combining molecular, genomic, phenotypic, clinical, and real-world data. AI drug discovery is clearly becoming a national priority.
2 · Reply
MrHurts
MrHurts Jul. 22 at 8:25 PM
$ABCL C'mon 😤😠
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 22 at 8:24 PM
$ABCL $ABCL dont be fooled, 2.5 million shares traded in a day is WAAAAY under volume.
0 · Reply
Rastafari
Rastafari Jul. 22 at 8:21 PM
$ABCL not the outcome I expected today, but stay calm. Our day is coming.
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 7:39 PM
$ABCL disgusting company
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 22 at 6:42 PM
$ABCL Share Price: $5.84 Contract Selected: Jan 15, 2027 $5 Calls Buy Zone: $1.53 – $1.89 Target Zone: $2.82 – $3.45 Potential Upside: 74% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 6:16 PM
$ABCL great this continues to drop as if there is no tomrrow . however management has zero accountability for share holders except paper tradees with adding and loafing repeated comments this POS stock has nothing
0 · Reply
8008track
8008track Jul. 22 at 5:55 PM
$ABCL for the record book - good or bad. I bought more today at $5.88. Not sure what the price action will be for the next couple of weeks but I’m happy to pick up additional shares and be invested. All that matters is abcl635 read out. 71 days remaining in q3.
1 · Reply
tradersunion353
tradersunion353 Jul. 22 at 4:49 PM
$ABCL so the leaked ABCL 635 phase 2 data is bad is correct... This pos company has been overhyping this 635 for such a long time.... CEO needs to answer to investors
0 · Reply
psyxopathis
psyxopathis Jul. 22 at 4:41 PM
$ABCL i started my thesis yesterday at 5.66$ after studying the company very long time. Is there anything i am missing because from all the digging i did, the only statement i was making to myself was, too good to be true. I am here for the long term by the way. Anything useful that i might missed, please fire up.
1 · Reply
DeMampCamp
DeMampCamp Jul. 22 at 4:15 PM
$ABCL Volume has fallen off a cliff today, looks like all the weak hands are gone and now we just await the phase 2 results/readout! Happy Wednesday all!
1 · Reply
tradersunion353
tradersunion353 Jul. 22 at 3:54 PM
$ABCL POS really want to drp to 1-2 dollars Management should come out clear the smoke about the rummours of leaked bad phase 2 data Investors have suffered enough for last 5 years... with shty stock performance
0 · Reply
Currencywolf
Currencywolf Jul. 22 at 2:33 PM
Been banking off @TopSarge alerts these past few weeks. The entries have been insane! Don’t sleep, go give him a follow 🔥 $CORZ $ABCL $BLSH $SBET good opportunities
0 · Reply
Stockingtrade
Stockingtrade Jul. 22 at 2:17 PM
$ABCL Profit-taking and consolidation over the last couple weeks on low volume - I think the next wave starts this week. We’re now two weeks until the Aug 6 call, at which point they’ll either tell us the phase 2 results, or tell us when they will be ready to be published, either of which will cause big moves. And if the results are positive, could be looking at $12+ territory. Can’t wait!!
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 1:52 PM
$ABCL If management does not come out and do a PR about leaked data this garbage willl drop to 1-2 dollars
0 · Reply
tradersunion353
tradersunion353 Jul. 22 at 1:50 PM
$ABCL with leaked ABCL phase 2 data rumour until shameless management do a PR a clear the smoke
0 · Reply
Rastafari
Rastafari Jul. 22 at 1:17 PM
$ABCL bull vs bears thesis: who wins today? I’ll go first: Bull win up .30cents!
1 · Reply
tradersunion353
tradersunion353 Jul. 22 at 11:21 AM
$ABCL shame on management - should have come out and address the rumours about leaked phase 2 bad data - shareholders suffer 40% loss in 2 weeks such a pos company
0 · Reply
Cryptocr7
Cryptocr7 Jul. 22 at 9:57 AM
$ABCL could be way off the mark but suspect the downturn here is not related phase 2 results but more trumps beef with Canada
0 · Reply
XxZeeMoneyxX
XxZeeMoneyxX Jul. 22 at 7:54 AM
$ABCL just getting primed!
0 · Reply